Search

Your search keyword '"Ratziu, Vlad"' showing total 1,027 results

Search Constraints

Start Over You searched for: Author "Ratziu, Vlad" Remove constraint Author: "Ratziu, Vlad" Language english Remove constraint Language: english
1,027 results on '"Ratziu, Vlad"'

Search Results

5. Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort

6. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide

11. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

12. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

14. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

16. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

17. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

18. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

19. A global research priority agenda to advance public health responses to fatty liver disease

22. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

23. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

29. NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned

30. Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study

39. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

40. Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study.

42. Advancing the global public health agenda for NAFLD: a consensus statement

48. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study

49. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

50. MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials.

Catalog

Books, media, physical & digital resources